Headline News

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Paul Smith of Orasis Pharmaceuticals announces the closing of a $78 million financing round that will help the company move toward the launch of Qlosi for presbyopia.

A proof-of-concept trial revealed that GA2, a second-generation vaccine candidate that uses genetically attenuated malaria parasites, prevented 89% of participants who received it from being infected with malaria.

BOSTON — Patients with hereditary angioedema may down-titrate lanadelumab treatment while exhibiting symptom control, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Receiving a benralizumab injection during an acute asthma or COPD exacerbation with a blood eosinophil count of at least 300 cells/µL led to fewertreatment failures, according to results published in The Lancet Respiratory Medicine.

Healio has compiled the most-read news in pulmonology posted in November.

Baseline concomitant exposure to commonly used medications, such as corticosteroids and 5-aminosalicylates, did not significantly affect clinical and endoscopic outcomes during induction therapy in ulcerative colitis, data analysis showed.

WASHINGTON — Healio spoke with Jeffrey A. Sparks, MD, MMSc, about baseline results from the SAIL-RA study, which assesses which patients with rheumatoid arthritis may be at risk for developing interstitial lung disease.

WASHINGTON — Preexisting autoimmune diseases do not increase mortality risk in patients treated with immune checkpoint inhibitors for cancer, according to data presented at ACR Convergence 2024.

Treatment with immune checkpoint inhibitors appeared linked with higher risk for venous thromboembolism among adults with metastatic lung cancer, according to study results presented at CHEST Annual Meeting.

An AI model classified risk for prostate cancer metastasis more accurately than standard guidelines, suggesting the approach could be used to reduce overtreatment or undertreatment.